<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Adhesion</z:e> of myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells to the bone marrow (BM) microenvironment is mediated in part by Beta 1 and Beta 2 integrins </plain></SENT>
<SENT sid="1" pm="."><plain>Cells of the <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> line K562, derived from a patient with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, bind to BM fibroblasts (BMFs) but the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> cannot be accounted for by integrins or other known <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> proteins including CD44 or members of the Ig or selectin families </plain></SENT>
<SENT sid="2" pm="."><plain>Membrane fragments from K562 cells were radioiodinated and allowed to adhere to BMF monolayers </plain></SENT>
<SENT sid="3" pm="."><plain>Adherent proteins were solubilized together with the fibroblasts, analyzed by <z:chebi fb="0" ids="8984">sodium dodecyl sulfate</z:chebi>-<z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis, and visualized by autoradiography </plain></SENT>
<SENT sid="4" pm="."><plain>Four adherent proteins were consistently observed </plain></SENT>
<SENT sid="5" pm="."><plain>Two of these, with reduced molecular weights of 52 kD and 35 to 37 kD, were prominent </plain></SENT>
<SENT sid="6" pm="."><plain>Addition of soluble thrombospondin and <z:chebi fb="5" ids="28304">heparin</z:chebi> but not fibronectin inhibited binding of K562 membrane proteins to adherent BMFs and immobilized thrombospondin- and <z:chebi fb="5" ids="28304">heparin</z:chebi>-bound K562 proteins </plain></SENT>
<SENT sid="7" pm="."><plain>The 52-kD protein has a multimeric structure nonreduced and has characteristics of a <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Its <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to fibroblasts is divalent cation and temperature sensitive </plain></SENT>
<SENT sid="9" pm="."><plain>The 35- to 37-kD protein, whose function is divalent cation but not temperature sensitive, is phosphoinositol-linked and has characteristics identical to an adherent 35- to 37-kD protein identified on murine progenitor cells </plain></SENT>
<SENT sid="10" pm="."><plain>Membrane preparations from two cases of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> showed an adherent 35- to 37-kD protein and in one case an adherent 52-kD protein without other adherent bands </plain></SENT>
<SENT sid="11" pm="."><plain>A K562 subclone with reduced adherence to BMFs showed reduced amounts of adherent 52-kD and 35- to 37-kD proteins </plain></SENT>
<SENT sid="12" pm="."><plain>These proteins may be responsible for the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of malignant and <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic progenitor cells to the BM microenvironment </plain></SENT>
</text></document>